If you're among the many Americans that have metal-on-metal implants, you have a vested interest in knowing what's under the hood, so to speak. According to a study funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (Bethesda, MD), what's under the hood of metal-on-metal hip implants is graphitic carbon lubricant.
In what is being billed as FDA's first polymer collaboration, the federal agency and the Austen BioInnovation Institute in Akron (ABIA; Akron, OH) have begun working together to support and develop regulatory science for the safe and effective use of biomaterials in medical devices.
Last week, I reported on the presumed benefits of an artificial pancreas that could revolutionize diabetes treatment, noting that substantial disaffection from many quarters has been expressed toward FDA's apparent resistance to approving the development of the technology.
Working to exploit the powers of nanotechnology, scientists at the University of Zurich (Switzerland) are developing nanomagnets with the goal of using them someday to cleanse the blood of diseases. For example, the technology could eventually find its way into treatments for patients suffering from drug intoxication, bloodstream infections, and cancers.